Does INFLIXIMAB-DYYB Cause Nasal congestion? 775 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 775 reports of Nasal congestion have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 3.0% of all adverse event reports for INFLIXIMAB-DYYB.
775
Reports of Nasal congestion with INFLIXIMAB-DYYB
3.0%
of all INFLIXIMAB-DYYB reports
4
Deaths
176
Hospitalizations
How Dangerous Is Nasal congestion From INFLIXIMAB-DYYB?
Of the 775 reports, 4 (0.5%) resulted in death, 176 (22.7%) required hospitalization, and 3 (0.4%) were considered life-threatening.
Is Nasal congestion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 775 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-DYYB Cause?
Off label use (14,256)
Condition aggravated (10,275)
Intentional product use issue (7,549)
Inappropriate schedule of product administration (5,977)
Arthralgia (4,615)
Drug ineffective (3,112)
Fatigue (3,111)
Weight increased (2,848)
Malaise (2,766)
Weight decreased (2,703)
What Other Drugs Cause Nasal congestion?
DUPILUMAB (3,250)
AMBRISENTAN (3,019)
TREPROSTINIL (2,053)
OMALIZUMAB (1,883)
ADALIMUMAB (1,615)
MACITENTAN (1,497)
ALBUTEROL (1,434)
ETANERCEPT (1,379)
NIRMATRELVIR\RITONAVIR (1,339)
TOFACITINIB (1,325)
Which INFLIXIMAB-DYYB Alternatives Have Lower Nasal congestion Risk?
INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX
INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B